Patent ID: 11891445
Assignee: ABL BIO INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  G | IPC A  C  G

Claim 12:
13. A method for diagnosing a disease related to overexpression of B7-H3, comprising
a step of contacting the antibody or its antigen-binding fragment according to claim 1 with a biological sample, and
a step of determining the biological sample or a patient from who the biological sample obtained as having a disease related to overexpression of B7-H3, when B7-H3 is present or the concentration of B7-H3 is increased in the biological sample as compared to a control group contacted with the antibody or its antigen-binding fragment,
wherein the disease related to overexpression of B7-H3 is cancer.